Legal Challenge to FDA’s Evidentiary Standard for Dietary Supplement Health Claims: Regulatory Implications for Industry
The FDA dietary supplement health claims framework requires that disease-related claims meet the Significant Scientific Agreement (SSA) standard under 21 CFR 101.14. A recent legal challenge questions whether the SSA threshold is overly restrictive, potentially impacting dietary supplement compliance and claim substantiation requirements.

